Question explored with the scientific record
What's the evidence on statins and muscular pain?
The short version: statins really do cause muscle pain in some people, but the honest trial evidence is smaller and messier than either side admits.
The best evidence here is STOMP, a randomized, double-blind, placebo-controlled trial in 420 healthy, statin-naive people. Protocol-defined myalgia hit 19 of 203 on atorvastatin versus 10 of 217 on placebo, about 9 in 100 versus 5 in 100, and the difference just missed statistical significance [3][5]. Reanalyzing with dropouts included pushed the p-value to 0.08 [5]. That is a real signal in the right direction, not proof. The trial was young, healthy people treated six months, so it cannot tell you about a 70-year-old on a high dose for a decade [5].
The messier truth is in GAUSS-3. Among people who already blamed statins for muscle pain, 42.6% got symptoms on atorvastatin only, but 26.5% got them on placebo only, and 17.3% got them on neither [5]. A large share of "statin myalgia" is not the statin. Meanwhile a review of 44 statin trials found only one actually asked about muscle symptoms [5], so the trial literature was never built to count this harm.
| Group | Muscle pain | Notes |
|---|---|---|
| STOMP atorvastatin | 19/203 (9.4%) | p=0.054 [3][5] |
| STOMP placebo | 10/217 (4.6%) | [3][5] |
| GAUSS-3 atorvastatin only | 209 (42.6%) | presumed-sufferers [5] |
| GAUSS-3 placebo only | 130 (26.5%) | [5] |
| GAUSS-3 neither | 85 (17.3%) | [5] |
Dose matters. In 192 statin users, myalgia was common but did not differ between high and moderate doses, though that study had no non-statin control [1]. A Korean cohort found 7% reporting new muscle pain on atorvastatin, but only 3.4% meeting criteria for probable statin-related myalgia [2]. Risk factors include advanced age, female sex, small body frame, high dose, and drug interactions [4]. CoQ10 has not worked in a meta-analysis of 10 studies [5], and vitamin D trials including VITAL showed no benefit [6].
My call: statin muscle pain is real for a minority and dose-related, but many who blame statins are mistaken, and the trials were never designed to measure it well. Confidence: moderate.
Sources used 6
-
Myalgia in Patients on High‐Dose and Low‐to‐Moderate Dose Statin Therapy
In 192 statin users, myalgia was common but did not differ significantly between high-dose and low-to-moderate dose groups, and analgesic use and self-reported adherence were similarly not different.
DOI: 10.1002/j.2055-2335.2009.tb00453.x -
A Prospective Single-Center Study of Incidence of Atorvastatin-Induced Myalgia in Korean Patients: Application of the Statin Myalgia Clinical Index
In 89 Korean dyslipidemia patients, 6 (7%) reported new unexplained muscle pain on atorvastatin, but only 3.4% (3/87) met SMCI criteria for possible or probable atorvastatin-associated myalgia.
DOI: 10.17340/jkna.2022.1.3 -
Effect of Statins on Skeletal Muscle Function
The STOMP study investigates the effects of atorvastatin on muscle performance and the incidence of muscle complaints in healthy, statin-naive individuals, finding no significant impact on muscle strength or exercise capacity, but an increased incidence of myalgia associated wit…
DOI: 10.1161/circulationaha.112.136101 -
Narrative Review: Statin-Related Myopathy
This narrative review synthesizes current knowledge on statin-related myopathy, detailing definitions, mechanisms, epidemiology, clinical features, risk factors, management strategies, and emerging pharmacogenetic and adjunctive treatment data.
DOI: 10.7326/0003-4819-150-12-200906160-00009 -
What to Believe and Do About Statin-Associated Adverse Effects
This Viewpoint argues that statins' vascular benefits outweigh their rare adverse effects, but clinicians should acknowledge, investigate, and collaboratively manage statin-associated muscle symptoms despite ongoing uncertainty about mild myalgia.
DOI: 10.1001/jama.2016.16557 -
Statin-Associated muscle symptoms and vitamin D supplementation
This narrative review examines evidence on vitamin D supplementation for statin-associated muscle symptoms (SAMS), finding observational data suggest benefit while large randomized clinical trials, including VITAL, show no benefit in preventing SAMS or reducing statin discontinu…
DOI: 10.1097/hco.0000000000001222